Santaris Pharma A/S
http://www.santaris.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Santaris Pharma A/S
Pfizer’s Dolsten Plans Exit, Ushering In R&D Transition
Chief scientific officer and president of Pfizer Research & Development Mikael Dolsten will depart the company after a successor is appointed, likely early next year.
In Saudi Arabia, A Vision Of Healthcare Spurs Growth
As the Kingdom of Saudi Arabia reduces its dependence on oil as an export, one sector it is building up is the life sciences industry. The government is encouraging global companies to manufacture and invest domestically and they are improving their regulatory system and working with local players to enhance access to patients.
Remembering Japan Pharma Veteran Bill Bishop
Biopharma sector in Japan and Asia shocked by death of industry veteran and long-time Japan resident Bill Bishop and two family members in violent Christmas Day attack at their home in Saitama.
Remembering Japan Pharma Veteran Bill Bishop
Biopharma sector in Japan and Asia shocked by death of industry veteran and long-time Japan resident Bill Bishop and two family members in violent Christmas Day attack at their home in Saitama.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice